{
    "id": "333f0ca9-928d-45af-92b9-9ea8a4d02f7d",
    "indications": "micardis angiotensin ii receptor blocker ( arb ) indicated : treatment hypertension , lower blood pressure . lowering blood pressure reduces risk fatal nonfatal cardiovascular events , primarily strokes myocardial infarctions . ( 1.1 ) cardiovascular ( cv ) risk reduction patients unable take ace inhibitors ( 1.2 )",
    "contraindications": "may administered without food ( 2.1 ) used cardiovascular risk reduction , monitoring blood pressure recommended , appropriate , adjustment medications lower blood pressure may necessary ( 2.2 ) indication starting dose dose range hypertension ( 2.1 ) 40 mg daily 40 80 mg daily cardiovascular risk reduction ( 2.2 ) 80 mg daily 80 mg daily",
    "warningsAndPrecautions": "micardis available white off-white , uncoated tablets containing telmisartan 20 mg , 40 mg , 80 mg. tablets marked boehringer ingelheim company symbol one side , side , either `` 50h `` , `` 51h `` , `` 52h `` 20 mg , 40 mg , 80 mg strengths , respectively . tablets provided follows : micardis tablets 20 mg round individually blister-sealed cartons 30 tablets 3 x 10 cards ( ndc 0597-0039-37 ) . micardis tablets 40 mg oblong shaped individually blister-sealed cartons 30 tablets 3 x 10 cards ( ndc 0597-0040-37 ) . micardis tablets 80 mg oblong shaped individually blister-sealed cartons 30 tablets 3 x 10 cards ( ndc 0597-0041-37 ) . storage store 20°c 25°c ( 68°f 77°f ) ; excursions permitted 15°c 30°c ( 59°f 86°f ) [ usp controlled room temperature ] . tablets removed blisters immediately .",
    "adverseReactions": "micardis contraindicated patients known hypersensitivity ( e.g . , anaphylaxis angioedema ) telmisartan component product [ ( 6.2 ) ] . co-administer aliskiren micardis patients diabetes [ ( 7 ) ] .",
    "ingredients": [
        {
            "name": "TELMISARTAN",
            "code": "U5SYW473RQ"
        }
    ],
    "organization": "Boehringer Ingelheim Pharmaceuticals, Inc.",
    "name": "Micardis",
    "effectiveTime": "20250520",
    "indications_original": "MICARDIS is an angiotensin II receptor blocker (ARB) indicated for: Treatment of hypertension, to lower blood pressure. Lowering blood pressure reduces the risk of fatal and nonfatal cardiovascular events, primarily strokes and myocardial infarctions. (1.1) Cardiovascular (CV) risk reduction in patients unable to take ACE inhibitors (1.2)",
    "contraindications_original": "May be administered with or without food (2.1) When used for cardiovascular risk reduction, monitoring of blood pressure is recommended, and if appropriate, adjustment of medications that lower blood pressure may be necessary (2.2) Indication Starting Dose Dose Range Hypertension (2.1) 40 mg once daily 40 to 80 mg once daily Cardiovascular Risk Reduction (2.2) 80 mg once daily 80 mg once daily",
    "warningsAndPrecautions_original": "MICARDIS is available as white or off-white, uncoated tablets containing telmisartan 20 mg, 40 mg, or 80 mg. Tablets are marked with the Boehringer Ingelheim company symbol on one side, and on the other side, with either \"50H\", \"51H\", or \"52H\" for the 20 mg, 40 mg, and 80 mg strengths, respectively. Tablets are provided as follows:\n                  MICARDIS tablets 20 mg are round and individually blister-sealed in cartons of 30 tablets as 3 x 10 cards (NDC 0597-0039-37).\n                  MICARDIS tablets 40 mg are oblong shaped and individually blister-sealed in cartons of 30 tablets as 3 x 10 cards (NDC 0597-0040-37).\n                  MICARDIS tablets 80 mg are oblong shaped and individually blister-sealed in cartons of 30 tablets as 3 x 10 cards (NDC 0597-0041-37).\n                  \n                     \n                        Storage\n                     \n                     \n                     Store at 20°C to 25°C (68°F to 77°F); excursions permitted to 15°C to 30°C (59°F to 86°F)\t\t\t\t\t\t\t [see USP Controlled Room Temperature]. Tablets should not be removed from blisters until immediately before administration.",
    "adverseReactions_original": "MICARDIS is contraindicated in patients with known hypersensitivity (e.g., anaphylaxis or angioedema) to telmisartan or any other component of this product \n                        [see Adverse Reactions (6.2)]\n                     .\n                  Do not co-administer aliskiren with MICARDIS in patients with diabetes [see Drug Interactions (7)]."
}